Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Crystal Engineering . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112624992B reveals a purification breakthrough for risperidone intermediates. Achieve 99.9% purity and stable supply chain for API manufacturing.
Patent CN101555235B details a high-yield ethanol-based synthesis route for piperazine ferulate, offering significant supply chain stability and cost advantages for pharmaceutical manufacturing.
Novel rod-shaped crystal preparation method ensures high filtration efficiency and purity for polyetherimide intermediates, offering significant cost and supply chain advantages.
Patent CN101768128B reveals a butanone-based purification method reducing D-isomers to <1.0%, offering significant cost and yield advantages for pharmaceutical manufacturers.
Patent CN111393412A details a high-yield refining method for Dabigatran Etexilate using acetone/water and ethyl acetate, ensuring >99.7% purity for reliable API supply chains.
Advanced purification method for 2,6-dihydroxynaphthalene achieving >99% purity. Cost-effective, non-toxic solvent system for reliable pharmaceutical intermediate supply.
Patent CN116354976A reveals a novel binary solvent purification method for camptothecin derivatives, achieving over 99% purity without column chromatography for reliable supply.
Patent CN101747352B reveals a novel crystallization method for biapenem intermediates using lower alcohols to enhance purity and filtration efficiency for industrial scale-up.
Patent CN101177398B details a novel purification method for Triflusal, achieving >99.5% purity via alkaline dissolution and THF/cyclohexane recrystallization, ensuring supply chain stability.
Advanced purification technology for Miriplatin eliminates homologous impurities and heavy metal residues, ensuring superior API quality and supply chain stability.
Advanced purification method for Glimepiride achieving >99.9% purity. Optimized solvent systems reduce impurities and ensure scalable manufacturing for diabetes medication supply chains.
Patent CN109134503B reveals a stable Ceftriaxone Sodium Tetrahydrate with superior flow and low hygroscopicity, offering significant supply chain advantages.
Patent CN112661744B reveals an isothermal purification method for Esomeprazole Sodium, achieving >99.5% purity with minimal R-enantiomer. Ideal for reliable pharmaceutical intermediate supply chains.
Advanced isothermal purification method for Esomeprazole Sodium achieving >99.5% purity. Reduces solvent residue and ensures supply chain stability for global API manufacturers.
Advanced purification method for Tedizolid Phosphate using absolute ethanol. Eliminates high-boiling solvents for superior purity and cost-effective API manufacturing.
Patent CN103739635A reveals a novel recrystallization method for 1,3,4,6-tetra-O-acetyl-beta-D-mannopyranose, significantly boosting yield and purity for reliable 18F-FDG production.